Clinical Trials Logo

Seasonal Allergies clinical trials

View clinical trials related to Seasonal Allergies.

Filter by:
  • None
  • Page 1

NCT ID: NCT02748798 Recruiting - Asthma Clinical Trials

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Start date: November 10, 2020
Phase: Early Phase 1
Study type: Interventional

The goal of this research is to optimize the MRI system to obtain ideal lung images using Hyperpolarized (HP) Noble and Inert Fluorinated Gases as contrast agents. Lung coils tuned to the frequencies of these gases will be used. This study will take place at TBRHSC in the Cardiorespiratory Department and in the Research MRI facility.

NCT ID: NCT02578914 Completed - Clinical trials for Allergic Conjunctivitis

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Start date: August 2015
Phase: Phase 2
Study type: Interventional

This is a randomized, parallel, single center, double masked, vehicle controlled study. The purpose of this study is to determine the activity and safety of NS2 in patients with grass, tree or ragweed-pollen induced seasonal allergic conjunctivitis . Subjects will be randomized 1:1 to receive multiple doses of NS2 Ophthalmic Drops (0.5%) or NS2 Ophthalmic Drops Vehicle (0.0%). Free aldehydes are thought to be related to inflammatory conditions such as allergic conjunctivitis. NS2, a small molecule aldehyde trap, is being evaluated to determine whether it may decrease inflammation by lowering aldehyde levels.

NCT ID: NCT00533208 Completed - Seasonal Allergies Clinical Trials

MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Start date: July 2003
Phase: Phase 2
Study type: Interventional

To assess the efficacy of MK0524 on seasonal allergies.